Physician-supervised GLP-1 receptor agonist therapy that regulates appetite and improves metabolic function to support meaningful, sustained weight loss.
Semaglutide is a physician-supervised GLP-1 receptor agonist that helps the body regulate appetite, slow gastric emptying, and improve insulin sensitivity — making it easier to eat less, feel satisfied longer, and lose weight steadily. Administered as a simple once-weekly injection, treatment is titrated over several weeks to minimize side effects while building toward an effective dose. Most patients see clinically meaningful weight loss of 10 to 15% of body weight, along with improvements in blood sugar control and overall metabolic health. Treatment is monitored throughout with lab work and follow-up visits to ensure progress and safety.
Semaglutide mimics GLP-1, a gut hormone that signals fullness to the brain, slows gastric emptying, and improves insulin sensitivity. Weekly injections under physician supervision reduce caloric intake and cravings while supporting metabolic health. Dosing is titrated gradually to maximize efficacy and minimize side effects.
Semaglutide mimics a natural gut hormone called GLP-1, which signals fullness, slows digestion, and reduces food cravings — making it easier to eat less and lose weight steadily.
Adults with a BMI of 27 or higher, especially those with weight-related health concerns or who have not seen results with diet and exercise alone. A physician consultation confirms eligibility.
Common early side effects include mild nausea, constipation, or fatigue. These typically improve within a few weeks as your body adjusts and your dose is gradually titrated up.
Some weight regain is common when treatment stops. We work with patients on lifestyle strategies and may extend or modify treatment to support long-term success.
Schedule your consultation with Dr. Parvataneni today.